One example is the stratification of risk in patients by FMD in COVID-19 (7), another the use of pleiomorphic therapies, including statins, glucocorticoids, and ACE-inhibitors, to stabilise vascular function in a non-specific manner in severe viral infection (235, 236). Here, ACE is linked to COVID-19.